JPWO2020178743A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020178743A5 JPWO2020178743A5 JP2021552603A JP2021552603A JPWO2020178743A5 JP WO2020178743 A5 JPWO2020178743 A5 JP WO2020178743A5 JP 2021552603 A JP2021552603 A JP 2021552603A JP 2021552603 A JP2021552603 A JP 2021552603A JP WO2020178743 A5 JPWO2020178743 A5 JP WO2020178743A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- seq
- hla
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813650P | 2019-03-04 | 2019-03-04 | |
| US62/813,650 | 2019-03-04 | ||
| PCT/IB2020/051812 WO2020178743A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022524992A JP2022524992A (ja) | 2022-05-11 |
| JP2022524992A5 JP2022524992A5 (https=) | 2023-03-13 |
| JPWO2020178743A5 true JPWO2020178743A5 (https=) | 2023-03-13 |
| JP7727547B2 JP7727547B2 (ja) | 2025-08-21 |
Family
ID=72337378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552603A Active JP7727547B2 (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220168346A1 (https=) |
| EP (1) | EP3935171A4 (https=) |
| JP (1) | JP7727547B2 (https=) |
| KR (1) | KR20210144739A (https=) |
| CN (1) | CN113785064B (https=) |
| AU (1) | AU2020231928A1 (https=) |
| BR (1) | BR112021017404A2 (https=) |
| CA (1) | CA3132435A1 (https=) |
| IL (1) | IL286042A (https=) |
| MX (1) | MX2021010538A (https=) |
| SG (1) | SG11202109594PA (https=) |
| TW (1) | TWI877145B (https=) |
| WO (1) | WO2020178743A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7748284B2 (ja) | 2019-03-04 | 2025-10-02 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| MX2021010541A (es) | 2019-03-04 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| CN113795586B (zh) | 2019-03-25 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1064022A4 (en) * | 1998-03-13 | 2004-09-29 | Epimmune Inc | HLA BINDING PROTEINS AND THEIR USE |
| AU2008206442B2 (en) * | 2007-01-12 | 2012-10-18 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | gp100-specific T cell receptors and related materials and methods of use |
| US9051391B2 (en) * | 2007-06-11 | 2015-06-09 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| US10441644B2 (en) * | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
| CN110139873A (zh) * | 2016-10-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | Hpv特异性结合分子 |
-
2020
- 2020-03-03 EP EP20765649.7A patent/EP3935171A4/en active Pending
- 2020-03-03 JP JP2021552603A patent/JP7727547B2/ja active Active
- 2020-03-03 WO PCT/IB2020/051812 patent/WO2020178743A1/en not_active Ceased
- 2020-03-03 AU AU2020231928A patent/AU2020231928A1/en active Pending
- 2020-03-03 MX MX2021010538A patent/MX2021010538A/es unknown
- 2020-03-03 SG SG11202109594P patent/SG11202109594PA/en unknown
- 2020-03-03 US US17/436,939 patent/US20220168346A1/en active Pending
- 2020-03-03 CA CA3132435A patent/CA3132435A1/en active Pending
- 2020-03-03 KR KR1020217031549A patent/KR20210144739A/ko active Pending
- 2020-03-03 CN CN202080025509.5A patent/CN113785064B/zh active Active
- 2020-03-03 BR BR112021017404A patent/BR112021017404A2/pt unknown
- 2020-03-04 TW TW109107112A patent/TWI877145B/zh active
-
2021
- 2021-09-01 IL IL286042A patent/IL286042A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022109953A5 (https=) | ||
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| JP2022169543A (ja) | 改善された養子ｔ細胞療法 | |
| US11052138B2 (en) | Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors | |
| CN109694854B (zh) | 通用型嵌合抗原受体t细胞制备技术 | |
| Spear et al. | Strategies to genetically engineer T cells for cancer immunotherapy | |
| JP2020509767A5 (https=) | ||
| JP2019519245A5 (https=) | ||
| CN112088008A (zh) | 修饰细胞的扩增及其用途 | |
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| JP2023534808A (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| WO2017070649A1 (en) | Combination methods for immunotherapy | |
| CN114616337A (zh) | 嵌合CD3融合蛋白与基于anti-CD3的双特异性T细胞激活元件的联合表达 | |
| JP2020533962A5 (https=) | ||
| JPWO2020194195A5 (https=) | ||
| JPWO2020048995A5 (https=) | ||
| JPWO2020178739A5 (https=) | ||
| JPWO2020178742A5 (https=) | ||
| CN113785064B (zh) | T细胞受体及其使用方法 | |
| JPWO2020178738A5 (https=) | ||
| JPWO2020178741A5 (https=) | ||
| JPWO2020178740A5 (https=) | ||
| JPWO2020178743A5 (https=) | ||
| Haas et al. | Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine. | |
| WO2019243888A1 (en) | Compositions and methods for making engineered t cells |